This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Point Judith Capital | |
|---|---|
| Name | Point Judith Capital |
| Type | Private |
| Industry | Venture capital |
| Founded | 2004 |
| Headquarters | Providence, Rhode Island |
| Key people | Matthew McKillop (Managing Partner), Sarah Kline (General Partner) |
| Products | Venture capital funds, growth equity |
| Assets | $1.2 billion (AUM, 2023) |
Point Judith Capital is a private venture capital firm focused on early-stage and growth-stage investments in technology, healthcare, and consumer sectors. Founded in 2004 and headquartered in Providence, Rhode Island, the firm has been active across the Northeastern United States and selectively in the Mid-Atlantic and California markets. Point Judith Capital is known for concentrated fund structures, founder-support programs, and active board participation.
Point Judith Capital was established in 2004 by a group of entrepreneurs and former investment professionals from institutions including Harvard Business School alumni networks, former partners from Bain & Company, and executives who had worked at Digital Equipment Corporation and Aetna. In its formative years the firm built early relationships with incubators and accelerators such as MassChallenge, Y Combinator, and Techstars alumni networks, and with university technology transfer offices from institutions like Brown University and Massachusetts Institute of Technology. The firm closed its first fund in 2006 and subsequently raised follow-on funds in 2010, 2015, and 2020, with limited partners drawn from endowments such as Yale University endowment offices, family offices linked to entrepreneurs from Microsoft and Oracle, and corporate pension funds including TIAA.
During the 2008 financial crisis Point Judith Capital reallocated portfolio resources to healthcare startups spun out of research programs at Johns Hopkins University and biotech incubators in the New England Biotech Corridor. In the 2010s the firm expanded its remit to include consumer brands incubated through platforms like BrandProject and direct-to-consumer pioneers who had scaled using Shopify and Stripe. By the late 2010s Point Judith Capital participated in growth rounds alongside firms such as Sequoia Capital, Accel, and Benchmark.
Point Judith Capital pursues a strategy blending seed-stage investments with follow-on growth equity, often leading or co-leading Series A and Series B rounds. The firm emphasizes founder-market fit and capital efficiency, preferring startups with product-market traction demonstrated through partnerships with enterprise customers like Pfizer, CVS Health, and UnitedHealth Group. Sector focus areas include healthcare technology with linkages to Genentech-style biotech commercialization, enterprise software adjacent to Salesforce ecosystems, and consumer brands leveraging digital marketing channels exemplified by Instagram and TikTok success stories.
Deal sourcing leverages relationships with university incubators such as Brown University's Nelson Center, accelerator cohorts from Techstars and Y Combinator, and corporate venture arms including Google Ventures and Intel Capital. Investment criteria often include defensible intellectual property, repeatable revenue models seen in firms like Zendesk or Shopify customers, and regulatory pathways when applicable through agencies like the Food and Drug Administration. Exit planning contemplates strategic acquisitions by acquirers such as Google, Amazon, and pharmaceutical firms including Roche and Novartis.
Point Judith Capital's portfolio spans software-as-a-service, healthcare devices, and consumer direct-to-consumer brands. Notable investments include early backing of a telehealth company later acquired by Teladoc Health, participation in growth rounds for an enterprise analytics startup partnering with Oracle and IBM, and seed investment in a personalized nutrition brand that scaled on Amazon and was later acquired by a multinational CPG conglomerate with ties to Unilever.
Other portfolio companies have partnered with research institutions such as Massachusetts General Hospital and Dana-Farber Cancer Institute for clinical validation, and commercial collaborations with logistics providers like FedEx and UPS. The firm has also invested in fintech ventures that integrated with Stripe and Plaid and in consumer marketplaces that achieved network effects similar to early-stage Etsy and Airbnb players.
Point Judith Capital is led by a team of general partners, operating partners, and venture partners with backgrounds at firms and institutions including Goldman Sachs, Morgan Stanley, McKinsey & Company, and technology companies such as Google and Microsoft. The managing partner, Matthew McKillop, formerly worked in private equity at a firm associated with JL Partners and holds degrees from Harvard University and Wharton School affiliates; other senior partners include Sarah Kline, with prior roles at Roche's venture group and at Massachusetts Institute of Technology spinouts.
Operational functions include a portfolio support group that assists companies with recruiting using networks tied to LinkedIn and executive search firms such as Korn Ferry, regulatory and clinical strategy teams that liaise with institutions like FDA consultants and contract research organizations akin to Parexel, and marketing support that taps advisors from Ogilvy and digital agencies experienced with social platforms such as Meta Platforms.
Point Judith Capital manages multiple funds with reported assets under management around $1.2 billion as of 2023. The firm reports distributions to limited partners through secondary sales, strategic acquisitions, and initial public offerings, having realized exits at valuations that produced multiples comparable to industry peers such as Bessemer Venture Partners and Union Square Ventures. Performance metrics emphasize internal rate of return (IRR) benchmarks common to venture capital, and the firm provides limited partners including sovereign wealth-linked investors and university endowments with periodic capital call schedules and audit-compliant reporting standards similar to those used by Cambridge Associates.
As a registered private investment firm, Point Judith Capital operates within regulatory frameworks overseen by agencies such as the Securities and Exchange Commission in matters of fundraising and accredited investor verification. The firm has engaged external counsel from law firms with venture capital practices that have represented clients before the SEC and in matters involving securities laws and intellectual property disputes. Portfolio companies have navigated regulatory pathways involving the Food and Drug Administration for medical devices and clinical trials, and data-privacy compliance with statutes influenced by frameworks like the California Consumer Privacy Act.
Category:Venture capital firms